Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
The 10 most significantly upregulated and 10 most significantly downregulated genes involved in inflammatory response
| Gene symbol | Gene name | Fold change | Adj. p.val |
|---|---|---|---|
| TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | 4.74 | <0.01 |
| CCL4L1 | chemokine (C-C motif) ligand 4—like 1 | 4.53 | <0.01 |
| SELE | selectin E | 3.76 | 0.01 |
| PTGER3 | prostaglandin E receptor 3 (subtype EP3) | 3.53 | <0.01 |
| CCL8 | chemokine (C-C motif) ligand 8 | 3.23 | <0.01 |
| JAK2 | Janus kinase 2 | 3.18 | <0.01 |
| TAC1 | tachykinin, precursor 1 | 3.17 | <0.01 |
| S100A9 | S100 calcium binding protein A9 | 3.15 | 0.02 |
| SPP1 | secreted phosphoprotein 1 | 2.97 | <0.01 |
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 2.58 | <0.01 |
| CCL14 | chemokine (C-C motif) ligand 14 | -2.43 | <0.01 |
| BMP6 | bone morphogenetic protein 6 | -2.45 | <0.01 |
| CFH | complement factor H | -2.63 | <0.01 |
| CD44 | CD44 molecule (Indian blood group) | -2.73 | <0.01 |
| C7 | complement component 7 | -2.78 | <0.01 |
| TRIL | TLR4 interactor with leucine-rich repeats | -2.95 | <0.01 |
| PDE2A | phosphodiesterase 2A, cGMP-stimulated | -2.98 | <0.01 |
| NLRC5 | NLR family, CARD domain containing 5 | -3.16 | <0.01 |
| CNR1 | cannabinoid receptor 1 (brain) | -3.27 | <0.01 |
| P2RX1 | purinergic receptor P2X, ligand-gated ion channel, 1 | -6.48 | <0.01 |